Skip to content

Clinical trials

Phase 4 Gram-Positive Bacterial Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gram-Positive Bacterial Infections Phase: Phase 4 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Hopital Lariboisière1
Pfizer1
University of Sao Paulo1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gram-Positive Bacterial Infections5
Bacteremia2
Sepsis2
Endocarditis1
Gram-Negative Bacterial Infections1
Multiple Organ Failure1
Pneumonia, Bacterial1
Shock, Septic1
Skin and Connective Tissue Diseases1
Soft Tissue Infections1

Trials

Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.